PL3482209T3 - Oznaczenie do wykrywania alfa-synukleiny i sposób diagnozowania alfa-synukleinopatii - Google Patents

Oznaczenie do wykrywania alfa-synukleiny i sposób diagnozowania alfa-synukleinopatii

Info

Publication number
PL3482209T3
PL3482209T3 PL17742509.7T PL17742509T PL3482209T3 PL 3482209 T3 PL3482209 T3 PL 3482209T3 PL 17742509 T PL17742509 T PL 17742509T PL 3482209 T3 PL3482209 T3 PL 3482209T3
Authority
PL
Poland
Prior art keywords
alpha
synucleinopathies
diagnosing
detection assay
synuclein
Prior art date
Application number
PL17742509.7T
Other languages
English (en)
Inventor
Alison Green
Graham FAIRFOUL
Original Assignee
The University Court Of The University Of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Court Of The University Of Edinburgh filed Critical The University Court Of The University Of Edinburgh
Publication of PL3482209T3 publication Critical patent/PL3482209T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4709Amyloid plaque core protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2835Movement disorders, e.g. Parkinson, Huntington, Tourette
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7047Fibrils-Filaments-Plaque formation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL17742509.7T 2016-07-07 2017-07-06 Oznaczenie do wykrywania alfa-synukleiny i sposób diagnozowania alfa-synukleinopatii PL3482209T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1611840.8A GB201611840D0 (en) 2016-07-07 2016-07-07 Alpha-synuclein detection assay
PCT/GB2017/051988 WO2018007817A1 (en) 2016-07-07 2017-07-06 Alpha-synuclein detection assay and method for diagnosing alpha-synucleinopathies

Publications (1)

Publication Number Publication Date
PL3482209T3 true PL3482209T3 (pl) 2024-04-08

Family

ID=56890945

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17742509.7T PL3482209T3 (pl) 2016-07-07 2017-07-06 Oznaczenie do wykrywania alfa-synukleiny i sposób diagnozowania alfa-synukleinopatii

Country Status (12)

Country Link
US (3) US11099197B2 (pl)
EP (2) EP4321871A3 (pl)
JP (1) JP6980750B2 (pl)
KR (1) KR102323688B1 (pl)
CN (2) CN109496272B (pl)
AU (1) AU2017292377B2 (pl)
CA (1) CA3029204A1 (pl)
ES (1) ES2964810T3 (pl)
GB (1) GB201611840D0 (pl)
HR (1) HRP20231592T1 (pl)
PL (1) PL3482209T3 (pl)
WO (1) WO2018007817A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201720975D0 (en) 2017-12-15 2018-01-31 Ucb Biopharma Sprl Anti-alpha synuclein antibodies
GB201720970D0 (en) 2017-12-15 2018-01-31 Ucb Biopharma Sprl Antibodies
GB201803553D0 (en) * 2018-03-06 2018-04-18 Univ Newcastle Detection of pathological protein aggregation
KR102069435B1 (ko) * 2018-03-27 2020-02-24 성균관대학교산학협력단 콧물액을 이용한 파킨슨 질환의 진단 방법, 이를 위한 조성물 및 이를 포함하는 키트
EP3922723A4 (en) * 2019-02-05 2022-04-06 Osaka University METHOD AND KIT FOR DISCRIMINATING BETWEEN PARKINSON'S DISEASE AND MULTIYSTEMA ATROPHY
CN114341343A (zh) * 2019-04-30 2022-04-12 才思治疗公司 α-突触核蛋白测定
JP7376040B2 (ja) * 2019-09-03 2023-11-08 国立大学法人京都工芸繊維大学 神経変性疾患におけるバイオマーカー分子の検出方法
AU2020343310A1 (en) 2019-09-04 2022-03-24 Amprion, Inc. Alpha-synuclein detection using beads
KR102277871B1 (ko) * 2019-12-17 2021-07-15 원광대학교산학협력단 소변의 알파-씨누클레인 중합체 측정에 의한 파킨슨병 진단 정보의 수집방법 및 그 키트
US20210223268A1 (en) * 2020-01-21 2021-07-22 Board Of Regents Of The University Of Texas System Discriminating parkinson's disease from multiple system atrophy using alpha-synuclein pmca
KR102466943B1 (ko) 2020-04-02 2022-11-14 한국과학기술연구원 갭을 갖는 바이오 센서를 이용한 파킨슨병 모니터링 방법 및 시스템
KR102376482B1 (ko) * 2020-08-21 2022-03-17 재단법인대구경북과학기술원 병원성 알파-시누클린 응집체의 씨딩 활성 유도 및 정량분석 방법
WO2022270901A1 (ko) * 2021-06-25 2022-12-29 장재원 동적 형광 또는 x-선의 표준편차와 자기상관을 활용한 조기 진단 시스템
CN115032400A (zh) * 2022-03-28 2022-09-09 首都医科大学附属北京天坛医院 α-突触核蛋白在辅助诊断神经退行性疾病中的用途
CN115043927B (zh) * 2022-06-17 2024-03-19 武汉大学 针对抗α-突触核蛋白K80Hcy抗体的抗原肽及其应用
WO2024089232A1 (en) 2022-10-28 2024-05-02 Stavanger University Hospital Alpha-synuclein detection assay comprising zinc ions in the reaction mixture and method for diagnosing alpha-synucleinopathies
WO2024144287A1 (ko) * 2022-12-30 2024-07-04 재단법인대구경북과학기술원 알파시누클레인에 의한 혈액-뇌장벽 손상 진단용 마커 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002544174A (ja) 1999-05-07 2002-12-24 ジェネンテック・インコーポレーテッド B細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療
WO2004073651A2 (en) * 2003-02-18 2004-09-02 The Ohio State University Research Foundation Identifying inhibitors of intracellular protein fibrillization
PT2307381T (pt) * 2008-06-09 2021-03-15 Univ Muenchen Ludwig Maximilians Novas drogas para inibir a agregação de proteínas envolvidas em doenças relacionadas com a agregação de proteínas e/ou doenças neurodegenerativas
US10989718B2 (en) * 2014-09-11 2021-04-27 Amprion, Inc. Detection of misfolded alpha synuclein protein
US20160077112A1 (en) 2014-09-11 2016-03-17 Board Of Regents Of The University Of Texas System Detection of Misfolded Proteins
US9588129B2 (en) * 2013-03-15 2017-03-07 Amira Medical Technologies Inc. Methods for analyzing blood to detect diseases associated with abnormal protein aggregation
WO2021040907A1 (en) 2019-08-30 2021-03-04 Alibaba Group Holding Limited Method and system for signaling chroma quantization parameter table

Also Published As

Publication number Publication date
ES2964810T3 (es) 2024-04-09
JP6980750B2 (ja) 2021-12-15
CA3029204A1 (en) 2018-01-11
US20210263049A1 (en) 2021-08-26
EP4321871A2 (en) 2024-02-14
EP3482209B1 (en) 2023-11-15
CN116930506A (zh) 2023-10-24
EP3482209A1 (en) 2019-05-15
US12078643B2 (en) 2024-09-03
KR20190027847A (ko) 2019-03-15
KR102323688B1 (ko) 2021-11-08
EP4321871A3 (en) 2024-05-08
AU2017292377A1 (en) 2019-02-07
WO2018007817A1 (en) 2018-01-11
CN109496272A (zh) 2019-03-19
GB201611840D0 (en) 2016-08-24
JP2019527353A (ja) 2019-09-26
US20210405069A1 (en) 2021-12-30
EP3482209C0 (en) 2023-11-15
HRP20231592T1 (hr) 2024-03-15
US20190302128A1 (en) 2019-10-03
US11360103B2 (en) 2022-06-14
AU2017292377B2 (en) 2023-06-15
US11099197B2 (en) 2021-08-24
CN109496272B (zh) 2023-07-25

Similar Documents

Publication Publication Date Title
EP3482209C0 (en) ALPHA SYNUKLEIN DETECTION TEST AND METHOD FOR DIAGNOSING ALPHA SYNUKLEINOPATHIES
IL265396A (en) Methods and compositions for detecting analytes
IL289907A (en) Methods and systems for identification and analysis of tested material
IL258804B (en) Systems and methods for adaptive detection - area of defects
EP3543880C0 (en) SYSTEM FOR DIAGNOSIS AND PROGNOSIS OF STROKE
HK1255351A1 (zh) 用於診斷和評估非酒精性脂肪性肝炎的方法
HK1204076A1 (en) Vehicle type identification method and vehicle fast inspection system using the method
PT3096784T (pt) Péptidos, dispositivos e métodos para a deteção de anticorpos de anaplasma
HK1244537A1 (zh) 凝血酶-抗凝血酶複合體的測定試劑及測定方法
HK1250778A1 (zh) 分析物檢測及其方法
GB201515693D0 (en) Method for antigen detection
EP3117213A4 (en) System and method for lateral flow immunoassay testing
PL3440364T3 (pl) Układ i sposób do badania materiałów
EP3472199C0 (en) COMP-PEPTIDE AND ANTIBODIES DIRECTED AGAINST IT FOR THE DIAGNOSIS OF OSTEOARTHRITIS
IL250402B (en) A method for detecting sickle cell disease and its application
GB201619509D0 (en) Sample detection device
EP3379255A4 (en) Detection method, detection device, and inspection kit
IL261734A (en) A method for detection and means for it
GB201705764D0 (en) Analyte detection method
SG11201706356XA (en) Methods and systems for experiment design and analysis
PT3165907T (pt) Métodos e sistemas para testes não destrutivos
GB201709503D0 (en) Method and device for assay improvement
HK1220294A1 (zh) 用於提供測量數據和測量數據檢測組件的方法
GB201721799D0 (en) Non-destructive testing means
ZA201808289B (en) Assay device and method for assessing blood cells